Leukemia, Lymphocytic, Chronic, B-Cell
Showing 9926 - 9950 of >10,000
Pulmonary Disease, Chronic Obstructive Trial in Union (Part A: RPL554, Part B: RPL554, Placebos)
Completed
- Pulmonary Disease, Chronic Obstructive
- Part A: RPL554
- +2 more
-
Union, South CarolinaVitaLink Research -- Union
Aug 29, 2022
Hepatocellular Carcinoma Trial (IPM001)
Not yet recruiting
- Hepatocellular Carcinoma
- IPM001
- (no location specified)
Sep 7, 2022
Acute Lymphoblastic Leukemia, Adult Trial in Mexico City (Gemcitabine, Busulfan, Cyclophosphamide)
Unknown status
- Acute Lymphoblastic Leukemia, Adult
- Gemcitabine
- +3 more
-
Mexico City, Distrito Federal, MexicoInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
Jan 10, 2020
COVID-19 Trial in Beijing (HH-120 nasal spray, PartA cohort 1, HH-120 nasal spray, Part A cohort 2-7, HH-120 nasal spray, Part A
Active, not recruiting
- COVID-19
- HH-120 nasal spray, PartA cohort 1
- +4 more
-
Beijing, Beijing, ChinaBeijing TongRen Hospital, Capital Medical University
Feb 23, 2023
Colonoscopy, Positive-Pressure Respiration Trial in Indianapolis (Nasal Cannula, Nasal Positive Airway Pressure System)
Not yet recruiting
- Colonoscopy
- Positive-Pressure Respiration
- Nasal Cannula
- Nasal Positive Airway Pressure System
-
Indianapolis, IndianaIndiana University
Mar 2, 2023
Pulmonary Fibrosis, Pulmonary Disease, Chronic Obstructive Trial in Québec, Lomme (Functional capacity tests)
Not yet recruiting
- Pulmonary Fibrosis
- Pulmonary Disease, Chronic Obstructive
- Functional capacity tests
-
Québec, Canada
- +1 more
Nov 6, 2023
Renal Cell Carcinoma (RCC) Trial in Birmingham (Trans-arterial embolization (TAE))
Not yet recruiting
- Renal Cell Carcinoma (RCC)
- Trans-arterial embolization (TAE)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 5, 2022
Acute Exacerbation of COPD Trial in Konya (Treatment group, Chair-Based Exercise Training, Control group, Breathing exercise)
Recruiting
- Acute Exacerbation of COPD
- Treatment group, Chair-Based Exercise Training
- Control group, Breathing exercise
-
Konya, TurkeyNecmettin Erbakan University Nezahat Keleşoğlu Faculty of Health
Sep 29, 2022
Distal Aortic Dissection, Dissection, Aortic Acute, Acute Type B Aortic Dissection (Uncomplicated) Trial in Houston (BMT+TEVAR,
Recruiting
- Distal Aortic Dissection
- +2 more
- BMT+TEVAR
- BMT
-
Houston, Texas
- +1 more
Jan 11, 2022
Long-term Benefit in Chronic Hepatitis B Patients After Standard
Completed
- Hepatitis B
- Peginterferon Alfa-2B
- Peginterferon Alfa-2A
-
Beijing, Beijing, China
- +27 more
Apr 11, 2021
Spinal Cord Injuries Trial in Chicago, Cambridge (Daily acute intermittent hypoxia, Room air (SHAM), Walking + tSTIM)
Not yet recruiting
- Spinal Cord Injuries
- Daily acute intermittent hypoxia
- +3 more
-
Chicago, Illinois
- +1 more
Sep 28, 2022
Metastatic NSCLC Trial (Pembrolizumab coformulated with hyaluronidase, Pemetrexed, Cisplatin)
Not yet recruiting
- Metastatic Non-small Cell Lung Cancer
- Pembrolizumab coformulated with hyaluronidase
- +6 more
- (no location specified)
Jan 27, 2023
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Dalpiciclib+cetuximab)
Recruiting
- Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
-
Shanghai, Shanghai, Chinathe Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
Feb 9, 2023
B-cell Non Hodgkin Lymphoma, Mature B-cell Leukemia Burkitt-type Trial in Worldwide (Vincristine, cyclophosphamide,
Unknown status
- B-cell Non Hodgkin Lymphoma
- Mature B-cell Leukemia Burkitt-type
- Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C
- Rituximab, Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C
-
Leuven, Belgium
- +9 more
Jun 13, 2017
Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB Trial in Redwood City, Worcester (EB-101 Surgical
Not yet recruiting
- Epidermolysis Bullosa
- +2 more
- EB-101 Surgical application of RDEB wounds
-
Redwood City, California
- +1 more
Feb 13, 2023
Chronic Hepatitis B Trial in Amsterdam (Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir
Completed
- Chronic Hepatitis B
- Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
-
Amsterdam, Noord-Holland, NetherlandsAcademic Medical Center
Mar 25, 2021
Unresectable Melanoma, Metastatic Melanoma Trial in Brussel, Amsterdam, Barcelona (NEO-PTC-01)
Recruiting
- Unresectable Melanoma
- Metastatic Melanoma
- NEO-PTC-01
-
Brussel, Belgium
- +2 more
Dec 5, 2022
Study of Factors Regulating Mast Cell Proliferation
Recruiting
- Mastocytosis
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Varicose Veins Trial in London (Class II Compression Stockings (no specific device used))
Completed
- Varicose Veins
- Class II Compression Stockings (no specific device used)
-
London, United KingdomCharing Cross Hospital, Imperial College London
Aug 4, 2022
Testicular Tissue Cryopreservation in Setting of
Recruiting
- Gender Dysphoria
- Transgender
- Infectious Disease Testing
- Gonadal Tissue Removal
-
Pittsburgh, PennsylvaniaMagee-Womens Hospital
Apr 13, 2023
Safety Issues Trial in Kunming (Stromal Vascular Fraction (SVF) combined with Functional self-assembling peptide nanofiber
Recruiting
- Safety Issues
- Stromal Vascular Fraction (SVF) combined with Functional self-assembling peptide nanofiber hydrogels
-
Kunming, Yunnan, ChinaKunming Tongren Hospital
Jul 27, 2023
Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,
Not yet recruiting
- Solid Tumors, Adult
- +7 more
- Alpelisib
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 21, 2022
Chronic Pain, Osteo Arthritis Knee Trial in Chicago (Transcranial Magnetic Stimulation)
Withdrawn
- Chronic Pain
- Osteo Arthritis Knee
- Transcranial Magnetic Stimulation
-
Chicago, IllinoisNorthwestern University
Feb 1, 2023
HPV Testing for Cervical Cancer Screening in Women Living With
Recruiting
- HIV Seropositivity
-
Saint-Denis, FranceCentre Hospitalier de Saint-Denis
Jul 20, 2023